Senior insider sale
President & CEO at MERSANA THERAPEUTICS, INC. — senior position signals high conviction
$7.3K
11.53K shares
What this filing means
PROTOPAPAS ANNA plans to sell 11.53K shares of MERSANA THERAPEUTICS, INC. valued at approximately $7.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/15/2025ACC: 0001104659-25-003873
DirectorOfficer· President & CEO
Since Jan 2019
11.53K
Shares to sell
$7.3K
Approx. market value
31.25K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Vesting of restricted stock unit grant
Services rendered
1/13/2025
31.25KTotal acquired31.25K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/13/2025 | Vesting of restricted stock unit grant Services rendered | 31.25K | — |
| Total | 31.25K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
11.53K
Market value
$7.3K
1/14/2025
Total
Units
11.53K
Value
$7.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
1/14/2025 | 11.53K | $7.3K | NASDAQ | Planned |
| Total | 11.53K | $7.3K | ||